Influenza vaccines with increased amounts of H3 antigen

Details for Australian Patent Application No. 2010212548 (hide)

Owner Novartis AG

Inventors Stohr, Klaus; Tsai, Theodore

Agent FB Rice

Pub. Number AU-A-2010212548

PCT Pub. Number WO2010/092477

Priority 61/207,368 10.02.09 US

Filing date 10 February 2010

Wipo publication date 19 August 2010

International Classifications

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

Event Publications

15 September 2011 PCT application entered the National Phase

  PCT publication WO2010/092477 Priority application(s): WO2010/092477

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010212550-Influenza vaccines with reduced amounts of squalene

2010212547-Influenza vaccine regimens for pandemic-associated strains